4 unknown, 1 recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 1 | Recruiting 1 |
Follow Targeted Therapy Technologies, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retinoblastoma Phase II Expanded Access Clinical Trial Chemoplaque also referred to as Episcleral Topotecan - Retinoblastoma | Phase 2 | Recruiting | Targeted Therapy Technologies, LLC | 30 | 2025-02-21 | 2026-05-22 |
| Topotecan Episcleral Plaque for Treatment of Retinoblastoma Episcleral Topotecan - Retinoblastoma | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 42 | 2021-06-16 | 2023-10-31 |
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole Episcleral Celecoxib - Macula Edema, Radiation Retinopathy | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 3 | 2021-03-05 | 2023-11-24 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole Episcleral Dexamethasone - Macular Edema, Radiation Retinopathy | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 2 | 2019-09-01 | 2023-11-24 |
| A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema Episcleral Dexamethasone - Refractory Diabetic Macular Edema | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 1 | 2019-04-03 | 2023-11-24 |
Epiretinal Membrane (2) · Retinal Vein Occlusion (2) · Retinoblastoma (2) · Uveitis, Intermediate (2) · Macular Edema (1)
United States (5)